Bulletin
Investor Alert

Cerecor Inc.

NAS: CERC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 25, 2020, 6:46 p.m.

/zigman2/quotes/201368871/composite

$

2.45

Change

+0.02 +0.82%

Volume

Volume 2,372

Quotes are delayed by 20 min

/zigman2/quotes/201368871/composite

Previous close

$ 2.25

$ 2.43

Change

+0.18 +8.00%

Day low

Day high

$2.26

$2.44

Open

52 week low

52 week high

$1.52

$6.19

Open

James A. Harrell

Presently, James A. Harrell holds the position of Chief Commercial Officer of Cerecor, Inc. He is also Owner & Principal at Nsci Group, Inc.

In his past career he held the position of Vice President-Marketing of Medimmune, Inc. and VP & General Manager-Specialty Pharmaceuticals at Covidien Ltd.

James A. Harrell received an undergraduate degree from Samford University.

Transactions

Date Shares Transaction Value
06/10/2020 6,391   Acquisition at $2.28 per share. 14,571
06/09/2020 10,000   Acquisition at $2.5 per share. 25,000
12/10/2019 3,064   Acquisition at $2.85 per share. 8,732
12/10/2018 4,156   Acquisition at $2.85 per share. 11,844

Officers and Executives

Mr. Michael F. Cola
Chief Executive Officer & Director
Mr. Christopher Sullivan
Chief Financial & Accounting Officer
Dr. Garry Arthur Neil
Chief Medical Officer
Dr. H. Jeffrey Wilkins
Chief Development Officer
Dr. Bernadine Heather Fraser
VP-Clinical Operations & Project Management
Mr. Joseph M. Miller
Director
Mr. James A. Harrell
Chief Commercial Officer
Dr. Sol J. Barer
Chairman
Dr. Suzanne Louise Bruhn
Independent Director
Dr. Gunnar Magnus Modee Persson
Independent Director
Mr. Phil Gutry
Independent Director
Mr. Steven Joseph Boyd
Independent Director
Link to MarketWatch's Slice.